Work

Modeling and Simulation Approach to Support Dosing and Study Design Requirements for Treating HIV-Related Neuropsychiatric Disease with the NK1-R Antagonist Aprepitant

FWCI: 0.874
Cites:
Cited by: 4
Related to: 10